In the latest trading session, Boston Scientific (BSX) closed at $42.63, marking a -4.52% move from the previous day.

zacks.com - 2026-07-14 19:01:15

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

zacks.com - 2026-07-10 10:30:38

A sharp rotation trade has taken over markets to start the second half of 2026, with investors dumping the year's biggest winners and piling into beaten-down names.

benzinga.com - 2026-07-09 15:45:03

Amazon and Nvidia have been caught up in the AI trade, but have flatlined so far in 2026. Steve Cohen's Point72 Asset Management sold Amazon and Nvidia in the first quarter.

fool.com - 2026-07-09 02:15:00

Boston Scientific (BSX) closed at $44.6 in the latest trading session, marking a -1.2% move from the prior day.

zacks.com - 2026-07-06 19:17:14

Relative to its all-time high of $109.50 reached in September 2025, Boston Scientific Corporation's share price has declined by almost 60% to trade at around $45.00 per share. To put my money where my mouth is, I purchased my last shares on June 30th at an average price of $42.83. My overall purchase price now stands at $45.52. As part of its Q1-26 earnings, Boston Scientific announced a significant outlook revision, reducing its organic growth guidance for fiscal 2026 to a range between 6.5% and 8.0%.

seekingalpha.com - 2026-07-06 11:59:49

In the most recent trading session, Boston Scientific (BSX) closed at $42.68, indicating a -1.84% shift from the previous trading day.

zacks.com - 2026-06-30 19:02:11

Boston Scientific has suffered a 50% share price decline amid decelerating growth and competitive threats, but fundamentals-based valuation now appears attractive. Growth in key segments like electrophysiology and Watchman has slowed due to increased competition, reimbursement cuts, and less impressive clinical trial data. Management now guides to sub-10% revenue growth (6.5%-8% for the year), but I still expect 7.5% annualized growth over five years and improving margins.

seekingalpha.com - 2026-06-25 13:18:10

In the most recent trading session, Boston Scientific (BSX) closed at $44.46, indicating a -2.5% shift from the previous trading day.

zacks.com - 2026-06-24 19:01:17

The latest trading day saw Boston Scientific (BSX) settling at $45.6, representing a +2.86% change from its previous close.

zacks.com - 2026-06-23 19:17:13

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

zacks.com - 2026-06-23 10:30:38

Boston Scientific (BSX) closed the most recent trading day at $44.95, moving 4.2% from the previous trading session.

zacks.com - 2026-06-17 19:01:05

Boston Scientific's shares have fallen over 50% year to date as the medtech company continues to walk back full-year 2026 guidance. Sell-side analysts remain relatively upbeat on the stock.

fool.com - 2026-06-13 00:15:00

Boston Scientific has experienced a ~53% collapse over twelve months, driven by guidance cuts, WATCHMAN deceleration, EP share loss, and a mixed CHAMPION-AF readout. FY26 guidance was cut to 6.5-8.0% organic growth and $3.34-$3.41 EPS, with management tempering long-term 10%+ growth expectations. BSX trades at a significant discount to peers (12.6x FY27E P/E), despite maintaining a robust ~8% revenue and ~10-11% EPS growth profile.

seekingalpha.com - 2026-06-12 11:49:51

TORONTO, June 08, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (TSX: BSX) (OTCQX: BSXGF) (the “Company” or “Belo Sun”) today announced a change to its in-country executive leadership team as the Volta Grande Gold Project advances toward its next phase of development. The Company announced that Adriano Espeschit will no longer serve as President, Brazil.

globenewswire.com - 2026-06-08 07:00:00

Boston Scientific (BSX) concluded the recent trading session at $48.85, signifying a +2.43% move from its prior day's close.

zacks.com - 2026-06-04 19:01:13

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

zacks.com - 2026-06-04 10:31:14

Share buybacks are one of the key ways that companies express confidence in their outlook. This is particularly true when shares take a large hit, as management teams look to retire shares at what they may believe is a depressed price.

marketbeat.com - 2026-06-01 14:20:33

TORONTO, June 01, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (TSX: BSX) (OTC: BSXGF) (the “Company” or “Belo Sun”) provides the following updates regarding a recent petition filed by the Brazilian Federal Prosecution Service (“MPF”) in civil public action No. 1002764-28.2025.4.01.3903 before the Federal Court of Altamira, Pará, Brazil.

globenewswire.com - 2026-06-01 07:30:00

Weak guidance, analyst target cuts and declining energy prices weighed on Zscaler, AutoZone, PDD Holdings and other large-cap stocks, making them last week's biggest losers.

feeds.benzinga.com - 2026-05-31 09:49:20

Boston Scientific Corporation (BSX) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript

seekingalpha.com - 2026-05-29 21:24:04

Boston Scientific and Abbott both posted solid quarterly growth, but analysts see stronger upside for Boston Scientific despite mounting operational pressures.

zacks.com - 2026-05-29 10:16:18

Sales of a key product line will likely be flat this quarter and next, company management said.

fool.com - 2026-05-29 04:47:58

Boston Scientific (BSX) concluded the recent trading session at $49.11, signifying a -2.68% move from its prior day's close.

zacks.com - 2026-05-28 19:01:11

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

benzinga.com - 2026-05-28 12:18:42

Pre-Market Stock Futures: Futures are trading lower on Thursday as new records are set almost daily, with the AI/Data center trade continuing to push stocks higher on Wednesday. All four major indices hit or closed Wednesday's session at record highs, with the legacy Dow Jones Industrial Average leading the way, up 0.36% at 50,664, setting... Here Are Thursday's Top Wall Street Analyst Research Calls: Agilent, Boston Scientific, Comfort Systems, Dick's Sporting Goods, Dominion Energy, Electronic Arts, First Solar, Trade Desk, Valvoline, and More

247wallst.com - 2026-05-28 08:15:19

The Bank of N.T. Butterfield and Son Limited (“Butterfield”) (NYSE: NTB | BSX: NTB.BH) has entered into a definitive agreement to acquire CIBC's 91.7% intere

gurufocus.com - 2026-05-28 06:00:00

Investors weigh softer WATCHMAN and urology demand against a still-active device pipeline and capital deployment moves, today, May 27, 2026.

fool.com - 2026-05-27 17:11:11

The medical device giant just opened its wallet for a stake in a privately held company with a groundbreaking product.

fool.com - 2026-05-27 14:15:00

On May 27, 2026, we delve into the DCF analysis for Boston Scientific Corp (BSX), a company currently facing significant price performance challenges. Over the

gurufocus.com - 2026-05-27 07:40:00

TORONTO, May 26, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX:BSX OTCQX:BSXGF) today is pleased to announce that each of the six individuals nominated for election as a director of Belo Sun at the Company's Annual and Special Meeting of Shareholders held on May 26, 2026 (the “Meeting”), was elected.

globenewswire.com - 2026-05-26 18:00:00

WATCHMAN's 19% growth and trial wins bolster Boston Scientific's push to expand its addressable market from 5M to 20M patients worldwide.

zacks.com - 2026-05-26 10:56:30

Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock?

zacks.com - 2026-05-22 12:32:35

TORONTO, May 21, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or the “Company”) (TSX: BSX, OTCQX: BSXGF) is pleased to provide an update regarding hearings held yesterday before the 6th Panel of the Federal Regional Court of the 1st Region (“TRF-1”) in relation to three judicial proceedings involving the Volta Grande Gold Project (the “Project”), located in Pará State, Brazil. DPU Appeal Dismissed One of the matters heard concerned the appeal filed by the Federal Public Defender's Office (“DPU”) and an indigenous association against a lower court decision that had dismissed for procedural reasons a civil public action related to the alleged need for supplementation of the Indigenous Component Study (“ECI”) and the performance of additional public consultation procedures.

globenewswire.com - 2026-05-21 07:00:00

Boston Scientific Corporation (NYSE:BSX) on Tuesday reported positive pivotal trial data for its investigational SEISMIQ 4CE Coronary Intravascular Lithotripsy catheter, with the device meeting both primary safety and effectiveness goals in patients with severely calcified coronary artery disease.

benzinga.com - 2026-05-19 12:01:31

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

zacks.com - 2026-05-19 10:30:35

Late-breaking data from global pivotal study achieved high rates of freedom from major adverse cardiac events and procedural success in patients with severe coronary artery disease MARLBOROUGH, Mass. and PARIS, May 19, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced positive results from the pivotal FRACTURE Investigational Device Exemption (IDE) trial evaluating the use of the SEISMIQ™ 4CE Coronary Intravascular Lithotripsy Catheter* to treat patients with severely calcified coronary artery disease (CAD).

prnewswire.com - 2026-05-19 06:31:00

On May 18, 2026, Boston Scientific Corp (BSX) shares rose 6.2%, bringing the current price to $55.92. This increase comes amid a challenging year for the compan

gurufocus.com - 2026-05-18 16:39:00

BSX expands into fast-growing medtech segments with acquisitions spanning urology, pain management and vascular devices.

zacks.com - 2026-05-18 15:17:25

Boston Scientific Corporation (NYSE:BSX) said it invested $1.5 billion in privately held MiRus, securing an approximately 34% equity stake and an exclusive option to acquire the company's investigational transcatheter aortic valve replacement (TAVR) business.

benzinga.com - 2026-05-18 14:40:52

U.S. medical device maker Boston Scientific said on Monday it has invested $1.5 billion in privately held ​MiRus LLC in return for a 34% equity ‌stake and potential access to the startup's heart-valve business.

reuters.com - 2026-05-18 07:35:13

MARLBOROUGH, Mass., May 18, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into an accelerated share repurchase (ASR) agreement with JPMorgan Chase Bank, National Association for $2 billion (the repurchase price) of its common stock, as part of its previously announced $5 billion share repurchase authorization.

prnewswire.com - 2026-05-18 07:00:00

Agreement includes exclusive option to acquire novel, balloon-expandable transcatheter aortic valve made with proprietary rhenium alloy MARLBOROUGH, Mass., May 18, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has invested $1.5 billion in return for an approximately 34% equity stake in MiRus LLC, a privately-held company developing and commercializing proprietary biomaterials, implants and procedural solutions for the treatment of cardiovascular and orthopedic diseases, including the SIEGEL™ Balloon Expandable Transcatheter Aortic Valve Replacement (TAVR) system.

prnewswire.com - 2026-05-18 06:30:00

Boston Scientific is down over 43% YTD, erasing years of gains amid guidance cuts and segment-specific weakness. I initiate BSX with a Buy rating, citing achievable guidance post-Q1 reset and easing sales comps in 2H, which could stabilize the stock. Key risks include further guidance cuts, persistent WATCHMAN and Urology segment weakness, and macro-driven procedure slowdowns.

seekingalpha.com - 2026-05-15 10:38:02

Miami International Holdings Announces Participation in Upcoming June Investor Conferences PR Newswire MIAMI and

gurufocus.com - 2026-05-15 07:00:00

BSX expands global reach with strong APAC growth, FARAPULSE momentum and new approvals driving gains across Europe and China.

zacks.com - 2026-05-14 14:06:28

Boston Scientific rides on cardiovascular device growth with FARAPULSE and WATCHMAN momentum, but margin pressure and weaker estimates cloud the outlook.

zacks.com - 2026-05-13 11:40:51

On May 13, 2026, we delve into a DCF analysis for Boston Scientific Corp (BSX), a company that has seen significant price fluctuations recently. The stock has e

gurufocus.com - 2026-05-13 07:06:00

TORONTO, May 12, 2026 (GLOBE NEWSWIRE) -- Belo Sun Mining Corp. (“Belo Sun” or “Company”) (TSX: BSX, OTCQB: BSXGF) today announces the commencement of technical studies relating to its Volta Grande Gold Project (“Project”) located in Pará State, Brazil, with the engagement of a mining consultant and the hiring of a Engineering Director.

globenewswire.com - 2026-05-12 17:00:00

Boston Scientific Corporation is a leading medtech innovator facing recent share price underperformance due to market share erosion in electrophysiology and sector-wide sentiment shifts. Despite competitive pressures, BSX maintains strong leadership in PFA, with Watchman and neuromodulation as promising growth drivers and a robust pipeline supported by strategic M&A. Management has improved operating and net margins, reduced short-term debt, and achieved ROIC above WACC, signaling efficient capital allocation and resilience despite slowing revenue growth.

seekingalpha.com - 2026-05-11 16:30:41